Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
fda
incyte
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
4
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
clinical trials
europe blog main
europe top stories
biogen
cancer immunotherapy
crispr-cas9
deals
eidos therapeutics
What
roundup
bio
days
activity
ahead
alliance
ambien
american
annual
approvals
asco
attendees
attention
biogen
biotech
black
bristol
buy
calls
camp’s
cancer
cash
changing
chicago
city
clamped
clinical
color
combinations
community’s
companies
continue
covid
crispr
debut
delays
developing
diamond
diamond’s
drug
Language
unset
Current search:
incyte
×
startups
×
" raleigh-durham blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More